Proteomic Analysis of Potential Targets for Non-Response to Infliximab in Patients With Ulcerative Colitis

• Main Authors: Lu Liu (Author), Dan Pu (Author), Dandan Wang (Author), Muhan Zhang (Author), Chuan Zhou (Author), Zhe Zhang (Author), Baisui Feng (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Infliximab (IFX) is a potent therapeutic agent used for the treatment of conventional refractory ulcerative colitis (UC). However, the high non-response rate of IFX brings difficulties to clinical applications. In the context of proteomics research, our study of differentially expressed...